Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model.
Itamar MegiddoAbigail ColsonDan ChisholmTarun DuaArindam NandiRamanan LaxminarayanPublished in: Epilepsia (2016)
Expanding and publicly financing epilepsy treatment in India averts substantial disease burden. A universal public finance policy that covers only first-line AEDs may not provide significant financial risk protection. Covering costs for both first- and second-line therapy and other medical costs alleviates the financial burden from epilepsy and is cost-effective across wealth quintiles and in all Indian states.